Are you Dr. Gunter?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 42 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
Zymequest Inc, Suite 436h
100 Cummings Center
Beverly, MA 01915Phone+1 978-232-8370
Summary
- Dr. Kurt Gunter, MD is a board certified pathologist in Beverly, Massachusetts. He is currently licensed to practice medicine in Illinois.
Education & Training
National Institutes of Health Clinical CenterResidency, Pathology-Anatomic and Clinical, 1987 - 1988
University of MarylandResidency, Pathology-Anatomic and Clinical, 1986 - 1987- National Institutes of Health Clinical CenterFellowship, Allergy and Immunology, 1982 - 1986
University of Kansas School of MedicineResidency, Pathology-Anatomic and Clinical, 1980 - 1982- University of Kansas School of MedicineClass of 1979
Certifications & Licensure
IL State Medical License 2007 - 2026- American Board of Pathology Anatomic Pathology
- American Board of Pathology Clinical Pathology
- American Board of Pathology Blood Banking/Transfusion Medicine
Clinical Trials
- Infusion of Specially Treated Umbilical Cord Stem Cells After Chemoradiation Treatment for Blood Cancers Start of enrollment: 2004 Mar 01
- Safety Study of ECO Conversion System For Red Blood Cells. Start of enrollment: 2005 Nov 01
- A Phase 3 Study Comparing the Effects of Intravenous Epoetin Hospira and Epoetin Alfa [Epogen] (Amgen) in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With Epoetin Start of enrollment: 2012 Jan 31
- Join now to see all
Publications & Presentations
PubMed
- 65 citationsInternational seminar on the red blood cells as vehicles for drugs.Yann Godfrin, Françoise Horand, Robert S. Franco, Emmanuelle Dufour, Elena Kosenko
Expert Opinion on Biological Therapy. 2012-01-01 - 28 citationsCurrent state of U.S. Food and Drug Administration regulation for cellular and gene therapy products: potential cures on the horizon.Michael Mendicino, Yong Fan, D.L. Griffin, Kurt C. Gunter, Karen Nichols
Cytotherapy. 2019-07-01 - 36 citationsPositioning a Scientific Community on Unproven Cellular Therapies: The 2015 International Society for Cellular Therapy PerspectiveMassimo Dominici, Karen Nichols, Alok Srivastava, Daniel J. Weiss, Paul Eldridge
Cytotherapy. 2015-12-01
Press Mentions
ENPP1 and ABCC6 Deficiency Data Presented at ASBMR 2024October 3rd, 2024- Inozyme Pharma Reports Second Quarter 2022 Financial Results and Provides Business UpdatesAugust 15th, 2022
- Athenex to Host Key Opinion Leader Webinar on CAR-NKT Approach to CancerNovember 30th, 2021
- Join now to see all
